Head and neck paragangliomas Paragangliomas and pheochromocytomas are rare, mostly benign neuroendocrine tumors, which are embryologically derived from neural crest cells of the autonomic nervous system. Paragangliomas are essentially the extra-adrenal counterparts of pheochromocytomas. As such this family of tumors can be subdivided into head and neck paragangliomas, pheochromocytomas and thoracic and abdominal extra-adrenal paragangliomas. Ten out of fifteen genes that contribute to the development of paragangliomas are more susceptible to the development of head and neck paragangliomas when mutated. Gene expression profiling revealed that pheochromocytomas and paragangliomas can be classified into two main clusters (C1 and C2) based on transcriptomes. These groups were defined according to their mutational status and as such strongly associated with specific tumorigenic pathways. The influence of the main genetic drivers on the somatic molecular phenotype was shown by DNA methylation and miRNA profiling. Certain subunits of succinate dehydrogenase (SDHx), von Hippel-Lindau (VHL) and transmembrane protein 127 (TMEM127) still have the highest impact on development of head and neck paragangliomas. The link between RAS proteins and the formation of pheochromocytoma and paragangliomas is clear due to the effect of receptor tyrosine-protein kinase (RET) and neurofibromatosis type 1 (NF1) in RAS signaling and recent discovery of the role of HRAS. The functions of MYC-associated factor X (MAX) and prolyl hydroxylase 2 (PHD2) mutations in the contribution to the pathogenesis of paragangliomas still remain unclear. Ongoing studies give us insight into the incidence of germline and somatic mutations, thus offering guidelines to early detection. Furthermore, these also show the risk of mistakenly assuming sporadic cases in the absence of definitive family history in head and neck paragangliomas.

Department of Biology and Medical Genetics 1st Faculty of Medicine and General University Hospital Charles University Prague Czech Republic

Department of Ear Nose and Throat and Maxillofacial Surgery 3rd Faculty of Medicine and Military University Hospital Charles University Prague Czech Republic

Department of Endocrinology and Metabolism 1st Faculty of Medicine and and General University Hospital Charles University Prague Czech Republic

Department of Otorhinolaryngology 3rd Faculty of Medicine and Kralovske Vinohrady University Hospital Charles University Prague Czech Republic

Department of Paediatric Haematology and Oncology 2nd Faculty of Medicine and University Hospital Motol Charles University Prague Czech Republic

Section on Medical Neuroendocrinology Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Bethesda United States

000      

00000naa a2200000 a 4500

001      

bmc19034451

003      

CZ-PrNML

005      

20191017153038.0

007      

ta

008      

191007s2019 xo f 000 0|eng||

009      

AR

024    7_

$a 10.4149/neo_2018_181208N933 $2 doi

035    __

$a (PubMed)31307198

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xo

100    1_

$a Guha, Anasuya $7 xx0229078 $u Department of Otorhinolaryngology, 3rd Faculty of Medicine and Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic

245    12

$a A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas / $c A. Guha, Z. Musil, A. Vicha, T. Zelinka, K. Pacak, J. Astl, M. Chovanec

520    9_

$a Head and neck paragangliomas Paragangliomas and pheochromocytomas are rare, mostly benign neuroendocrine tumors, which are embryologically derived from neural crest cells of the autonomic nervous system. Paragangliomas are essentially the extra-adrenal counterparts of pheochromocytomas. As such this family of tumors can be subdivided into head and neck paragangliomas, pheochromocytomas and thoracic and abdominal extra-adrenal paragangliomas. Ten out of fifteen genes that contribute to the development of paragangliomas are more susceptible to the development of head and neck paragangliomas when mutated. Gene expression profiling revealed that pheochromocytomas and paragangliomas can be classified into two main clusters (C1 and C2) based on transcriptomes. These groups were defined according to their mutational status and as such strongly associated with specific tumorigenic pathways. The influence of the main genetic drivers on the somatic molecular phenotype was shown by DNA methylation and miRNA profiling. Certain subunits of succinate dehydrogenase (SDHx), von Hippel-Lindau (VHL) and transmembrane protein 127 (TMEM127) still have the highest impact on development of head and neck paragangliomas. The link between RAS proteins and the formation of pheochromocytoma and paragangliomas is clear due to the effect of receptor tyrosine-protein kinase (RET) and neurofibromatosis type 1 (NF1) in RAS signaling and recent discovery of the role of HRAS. The functions of MYC-associated factor X (MAX) and prolyl hydroxylase 2 (PHD2) mutations in the contribution to the pathogenesis of paragangliomas still remain unclear. Ongoing studies give us insight into the incidence of germline and somatic mutations, thus offering guidelines to early detection. Furthermore, these also show the risk of mistakenly assuming sporadic cases in the absence of definitive family history in head and neck paragangliomas.

650    12

$a nádory hlavy a krku $x genetika $7 D006258

650    _2

$a lidé $7 D006801

650    _2

$a mutace $7 D009154

650    12

$a paragangliom $x genetika $7 D010235

655    _2

$a časopisecké články $7 D016428

700    1_

$a Musil, Zdeněk $7 xx0107856 $u Department of Biology and Medical Genetics, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic

700    1_

$a Vícha, Aleš, $d 1971- $7 xx0116880 $u Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic

700    1_

$a Zelinka, Tomáš $7 xx0074465 $u Department of Endocrinology and Metabolism, 1st Faculty of Medicine and and General University Hospital, Charles University, Prague, Czech Republic

700    1_

$a Pacák, Karel, $d 1958- $7 jo20000074102 $u Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States

700    1_

$a Astl, Jaromír, $d 1964- $7 jn20020716588 $u Department of Ear, Nose and Throat and Maxillofacial Surgery, 3rd Faculty of Medicine and Military University Hospital, Charles University, Prague, Czech Republic

700    1_

$a Chovanec, Martin, $d 1978- $7 xx0070641 $u Department of Otorhinolaryngology, 3rd Faculty of Medicine and Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic

773    0_

$w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 66, č. 5 (2019), s. 671-680

856    41

$u https://pubmed.ncbi.nlm.nih.gov/31307198 $y Pubmed

910    __

$a ABA008 $b A 1194 $c 659 $y p $z 0

990    __

$a 20191007 $b ABA008

991    __

$a 20191017153506 $b ABA008

999    __

$a ok $b bmc $g 1451111 $s 1073001

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 66 $c 5 $d 671-680 $e 20190629 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470

LZP    __

$b NLK118 $a Pubmed-20191007